Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
Francesca
F
Fioredda
Concetta
C
Micalizzi
Marina
M
Lanciotti
Carlo
C
Dufour
Laura Doria
LD
Lamba
Isabella
I
Fiocchi
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects*; D002675:Child, Preschool; D004334:Drug Administration Schedule; D004594:Electrophysiology; D005260:Female; D006801:Humans; D009431:Neural Conduction / Q000187:drug effects*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000503:physiopathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011782:Quadriplegia / Q000139:chemically induced* / Q000503:physiopathology; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects*
D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine